glp-1 obesity drug updates The FDA approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Study finds GLP-1 receptor agonists

Seeing your hair thin or fall out can be upsetting

And in this comparison, the clinical data is devastating for phentermine

What New Research Suggests Key Takeaways GLP-1 medications are established treatments for diabetes and obesity

Dosing and schedule All GLP-1s used for weight loss follow a step-up dosing schedule

Saxenda may be worth discussing if: You did not tolerate semaglutide or tirzepatide well, and liraglutide offers a different side-effect profile for you specifically You are between 12 and 17 years old and your clinician recommends liraglutide over semaglutide in your case You prefer a daily injection routine over a weekly one for habit or medical reasons You want one of the longest-established track records in the class with over a decade of real-world safety data Mounjaro vs Wegovy: what the head-to-head data actually says For years, comparing Mounjaro and Wegovy meant comparing separate trials in separate patient populations with different designs